© The Financial Times Ltd 2016 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
As of Apr 22, 2016, the consensus forecast amongst 32 polled investment analysts covering Roche Holding Ltd. advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts improved on Jun 02, 2003. The previous consensus forecast advised investors to hold their position in Roche Holding Ltd..
|Last year||3 months ago||2 months ago||4 weeks ago||Latest|
The 25 analysts offering 12 month price targets for Roche Holding Ltd. have a median target of 305.00, with a high estimate of 385.00 and a low estimate of 247.00. The median estimate represents a 23.33% increase from the last price of 247.30. View Full Financials
In 2015, Roche Holding AG reported a dividend of 8.10 CHF, which represents a 1.25% increase over last year. The 29 analysts covering the company expect dividends of 8.57 CHF for the upcoming fiscal year, an increase of 5.79%. View Full Financials
|Div growth (TTM)||+1.25 %|
On Jan 28, 2016, Roche Holding Ltd. reported semi annual 2015 earnings of 6.27 per share. View Full Interim Financials
|Average growth rate||-4.09 %|
Roche Holding Ltd. reported annual 2015 earnings of 13.49 per share on Jan 28, 2016.
The next earnings announcement from Roche Holding Ltd. is expected the week of Oct 20, 2016. View Full Annual Financials
|Average growth rate||+2.51 %|
Roche Holding AG reported semi annual 2015 revenues of 25bn. This missed the 25bn consensus estimate of the 7 analysts following the company. This was 0.29% above the prior year's period results. View Full Interim Financials
|Average growth rate||+1.22 %|
Roche Holding AG had revenues for the full year 2015 of 48bn. This was 1.44% above the prior year's results. View Full Annual Financials
|Average growth rate||+3.17 %|